Hey Spidey,
I have posed questions directly to you, among others in the past and you remained silent. If this is just the same old circles as you say, why did you break that silence? It was a pretty good comparison of 2 companies that started at similar times, in a similar field, with zero similarities between board and management experience. Must have thought it was a good one for you to respond to no?
I question you to your thoughts of the update, and you just said its 2 weeks old and was already discussed. Did you post anything when it was new enough for you. Now that 2 weeks has passed its irrelevant?
Or how I question the delays for preclinical results, the ones that use mice. No enrolment difficulties, doubtful ethical delays would come into play. Not all missed milestones are cut from the same cloth. But yet, no response.
Or how about other companies abilities to manufacture cells in commercial quantities that was discussed in the last week? That's pretty new don't you think? Allo had been making the claim that nobody can manufacture like we can since as long as I can remember. It was our ace in the hole. Allo tried to refute it with mab's or some other pretty funky terms. Where were my props on this new find? Lol.
.
How come you didn't weigh in on the subject, especially when Allo's throwing terms out that are more up your ally. Even Pluristem took down the info about others growing in Petri dishes from their presentations. I wonder why. But what are you're thoughts on this if its still new enough for you, or Allo's response is considered dealt with already, since nobody else broke their silence on the topic.
Mesoblast even uses the term 3d bioreactor on their website. Should we be concerned with that, or not discuss it. That goes for the 2000L biorectors that companies are using. Not worthy of conversation?
Allo does post a lot of useful links, that I can agree. But how do you remain silent on the added commentary that goes along with them? Why does nobody but a handful of us, question these thoughts. Do you agree with them, as yours and everyone's silence on the many subjects would tend to make one believe that people are in agreement with these highly improbably thoughts.
And we all know the clueless and sideline Sally and such, they throw out there. My skin is thick enough to respond to them, as I know most of the commentary section in his posts are made up. You want to praise him for his posts, yet base a decision not to respond to me because of what I say. Kind of double standard don't you think.
I. would like to talk about Israel Ben Yoram. I found a link showing Brainstorm was founded in 2013, so it is feasible that he was a director at that time. I'm sure his role there was crucial to the startup of that company. Wish I could find a reason somewhere as to why he left or they chose someone else. But why is he not still there and on our board.
Seems most of our board has to do with financial experience in startups. You know, doing raises, bringing investors in for when they do them. Why can't we have board members with serious experience in pharmaceutical companies? Maybe then we would be further along in all of our trials, and not masters of dilutions. We have long moved past the start up phase. Time to move along to board members who can assist in another field like partnering for once.
AI
